Drug Profile
NE 1704
Latest Information Update: 27 Jul 1995
Price :
$50
*
At a glance
- Originator Neose Technologies
- Class Anti-inflammatories
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 27 Jul 1995 Discontinued-Preclinical for Inflammation in USA (Unknown route)
- 31 May 1995 New profile
- 31 May 1995 Preclinical development for Inflammation in USA (Unknown route)